Down-regulation of proteolytic complexes following EBV activation in BL cells

Biochemical and Biophysical Research Communications

Volumn 352, Issue 4, 2007, Pages 947-952

  Matusali, Giulia ^a   Leo, Alessandra De ^a   Gavioli, Riccardo ^b   Bertelli, Laura ^a   Renzo, Livia Di ^a   Mattia, Elena ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Epstein Barr virus; Lytic cycle; Proteasome; TPPII

Indexed keywords

CASPASE; CHYMOTRYPSIN; PEPTIDASE; PROTEASOME; PROTEIN SUBUNIT; TRIPEPTIDE DERIVATIVE; TRIPEPTIDYL PEPTIDASE II; TRYPSIN; UBIQUITIN; VIRUS PROTEIN;

AKATA CELL; ARTICLE; BINDING AFFINITY; BURKITT LYMPHOMA; COMPLEX FORMATION; CONJUGATION; CYTOLYSIS; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; RAJI CELL; STRUCTURE ANALYSIS; VIRUS ACTIVATION; VIRUS LATENCY;

BURKITT LYMPHOMA; CELL LINE; DOWN-REGULATION; HERPESVIRUS 4, HUMAN; PEPTIDE HYDROLASES; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 4;

EID: 33845396676     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.11.127     Document Type: Article

References (30)

1. Thorley-Lawson D.A. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1 (2001) 75-82
2. Kieff E., and Rickinson A.B. Epstein Barr Virus and its replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott Williams & Wilkins, Philadelphia 2511-2573
3. Speck S.H., Chatila T., and Flemington E. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5 (1997) 399-405
4. Rickinson A.B., and Kieff E. Epstein Barr Virus. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology (2001), Lippincott Williams & Wilkins, Philadelphia 2575-2627
5. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
6. Lupas A., Koster A.J., and Baumeister W. Structural features of 26S and 20S proteasomes. Enzyme Protein 47 (1993) 252-273
7. Dick T.P., Nussbaum A.K., Deeg M., Heinemeyer W., Groll M., Schirle M., Keilholz W., Stevanovic S., Wolf D.H., Huber R., Rammensee H.G., and Schild H. Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J. Biol. Chem. 273 (1998) 25637-25646
8. Tanaka K., and Kasahara M. The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. Immunol. Rev. 163 (1998) 161-176
9. Gaczynska M., Rock K.L., and Goldberg A.L. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365 (1993) 264-267
10. Sijts A.J., Ruppert T., Rehermann B., Schmidt M., Koszinowski U., and Kloetzel P.M. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J. Exp. Med. 191 (2000) 503-514
11. Fruh K., Bartee E., Gouveia K., and Mansouri M. Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses. Virus Res. 88 (2002) 55-69
12. Lorenzo M.E., Jung J.U., and Ploegh H.L. Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments. J. Virol. 76 (2002) 5522-5531
13. Dantuma N.P., and Masucci M.G. The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies. Semin. Cancer Biol. 13 (2003) 69-76
14. Engels N., Merchant M., Pappu R., Chan A.C., Longnecker R., and Wienands J. Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module. J. Exp. Med. 194 (2001) 255-264
15. Winberg G., Matskova L., Chen F., Plant P., Rotin D., Gish G., Ingham R., Ernberg I., and Pawson T. Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases. Mol. Cell Biol. 20 (2000) 8526-8535
16. Ikeda M., Ikeda A., Longan L.C., and Longnecker R. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases. Virology 268 (2000) 178-191
17. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P.M., Klein G., Kurilla M.G., and Masucci M.G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375 (1995) 685-688
18. Brown K.D., Hostager B.S., and Bishop G.A. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J. Exp. Med. 193 (2001) 943-954
19. Dukers D.F., Meij P., Vervoort M.B., Vos W., Scheper R.J., Meijer C.J., Bloemena E., and Middeldorp J.M. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J. Immunol. 165 (2000) 663-670
20. Gavioli R., Frisan T., Vertuani S., Bornkamm G.W., and Masucci M.G. c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells. Nat. Cell Biol. 3 (2001) 283-288
21. Balow R.M., Tomkinson B., Ragnarsson U., and Zetterqvist O. Purification, substrate specificity, and classification of tripeptidyl peptidase II. J. Biol. Chem. 261 (1986) 2409-2417
22. Geier E., Pfeifer G., Wilm M., Lucchiari-Hartz M., Baumeister W., Eichmann K., and Niedermann G. A giant protease with potential to substitute for some functions of the proteasome. Science 283 (1999) 978-981
23. Wang E.W., Kessler B.M., Borodovsky A., Cravatt B.F., Bogyo M., Ploegh H.L., and Glas R. Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity. Proc. Natl. Acad. Sci. USA 97 (2000) 9990-9995
24. Kessler B., Hong X., Petrovic J., Borodovsky A., Dantuma N.P., Bogyo M., Overkleeft H.S., Ploegh H., and Glas R. Pathways accessory to proteasomal proteolysis are less efficient in major histocompatibility complex class I antigen production. J. Biol. Chem. 278 (2003) 10013-10021
25. Glas R., Bogyo M., McMaster J.S., Gaczynska M., and Ploegh H.L. A proteolytic system that compensates for loss of proteasome function. Nature 392 (1998) 618-622
26. Mattia E., Ceridono M., Chichiarelli S., and D'Erme M. Interactions of Epstein-Barr virus origins of replication with nuclear matrix in the latent and in the lytic phases of viral infection. Virology 262 (1999) 9-17
27. Takada K., and Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63 (1989) 445-449
28. Polack A., Delius H., Zimber U., and Bornkamm G.W. Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji. Virology 133 (1984) 146-157
29. Yuan J., Cahir-McFarland E., Zhao B., and Kieff E. Virus and Cell RNAs Expressed during Epstein-Barr Virus Replication. J. Virol. 80 (2006) 2548-2565
30. Lee S.J., Choi D., Rhim H., and Kang S. E3 ubiquitin ligase RNF2 interacts with the S6' proteasomal ATPase subunit and increases the ATP hydrolysis activity of S6'. Biochem. J. 389 (2005) 457-463